Black Diamond Therapeutics, Inc.·4

Feb 15, 4:11 PM ET

Jones Erika 4

4 · Black Diamond Therapeutics, Inc. · Filed Feb 15, 2023

Insider Transaction Report

Form 4
Period: 2023-02-13
Jones Erika
SEE REMARKS
Transactions
  • Award

    Common Stock

    2023-02-13+5,07510,150 total
  • Award

    Stock Option (Right to Buy)

    2023-02-13+60,00060,000 total
    Exercise: $2.92Exp: 2033-02-12Common Stock (60,000 underlying)
Footnotes (2)
  • [F1]The Reporting Person was previously granted performance-based Restricted Stock Units ("RSUs"). The vesting of 35% of the RSUs was subject to the achievement of certain performance criteria. As of the transaction date, the performance criteria were met, resulting in the vesting of 1,776 RSUs, with the remainder vesting on August 15, 2023, subject to the grantee's continuous service through such vesting date.
  • [F2]25% of the shares subject to this option shall vest and become exercisable on February 13, 2024, with the remainder vesting in 36 equal monthly installments thereafter.

Documents

1 file
  • 4
    tm236831-4_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT